GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Edap TMS SA (NAS:EDAP) » Definitions » EV-to-EBIT
中文

Edap TMS (Edap TMS) EV-to-EBIT : -9.87 (As of Apr. 24, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Edap TMS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Edap TMS's Enterprise Value is $215.55 Mil. Edap TMS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.85 Mil. Therefore, Edap TMS's EV-to-EBIT for today is -9.87.

The historical rank and industry rank for Edap TMS's EV-to-EBIT or its related term are showing as below:

EDAP' s EV-to-EBIT Range Over the Past 10 Years
Min: -8981.27   Med: -14.83   Max: 469.56
Current: -9.98

During the past 13 years, the highest EV-to-EBIT of Edap TMS was 469.56. The lowest was -8981.27. And the median was -14.83.

EDAP's EV-to-EBIT is ranked worse than
100% of 81 companies
in the Medical Distribution industry
Industry Median: 14.25 vs EDAP: -9.98

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Edap TMS's Enterprise Value for the quarter that ended in Dec. 2023 was $157.69 Mil. Edap TMS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.85 Mil. Edap TMS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -13.86%.


Edap TMS EV-to-EBIT Historical Data

The historical data trend for Edap TMS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edap TMS EV-to-EBIT Chart

Edap TMS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.12 -102.18 148.36 -164.80 -7.12

Edap TMS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -164.80 -40.05 -22.48 -12.88 -7.12

Competitive Comparison of Edap TMS's EV-to-EBIT

For the Medical Distribution subindustry, Edap TMS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edap TMS's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Edap TMS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Edap TMS's EV-to-EBIT falls into.



Edap TMS EV-to-EBIT Calculation

Edap TMS's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=215.545/-21.849
=-9.87

Edap TMS's current Enterprise Value is $215.55 Mil.
Edap TMS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edap TMS  (NAS:EDAP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Edap TMS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-21.849/157.688064
=-13.86 %

Edap TMS's Enterprise Value for the quarter that ended in Dec. 2023 was $157.69 Mil.
Edap TMS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edap TMS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Edap TMS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Edap TMS (Edap TMS) Business Description

Traded in Other Exchanges
Address
Parc d'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.